MEDTRONIC PLC will acquire privately held SPR Therapeutics for approximately $650 million in cash to expand its chronic pain portfolio. The deal provides the medical device leader with a non-permanent, 60-day therapy system designed for minimally invasive pain relief. This acquisition allows Medtronic to capture market share in the growing non-opioid, non-surgical treatment sector.

Expanding Minimally Invasive Pain Solutions